Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas - Wikidata - wikimedia - TriplyDB

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

http://www.wikidata.org/entity/Q56908048

about

Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity Epstein-Barr virus infection and posttransplant lymphoproliferative disorder Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system ly Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.Host genetics of Epstein-Barr virus infection, latency and disease.Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?Transplantation of the pancreas.CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management.Epstein-Barr virus infection in adult renal transplant recipients.Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia.B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation.Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.Post cardiac transplantation T-cell lymphoproliferative disorder presenting as a solitary lung nodule.Post-transplant lymphoproliferative disorder after pancreas transplantation: a United Network for Organ Sharing database analysis.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.Posttransplant lymphoproliferative disorders in kidney transplant recipients: a retrospective cohort analysis over two decades in Hong Kong.Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.Comprehensive review of post-organ transplant hematologic cancers.Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases.International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.Impact of the posttransplant lymphoproliferative disorder subtype on survival.Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network.Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study

P2860

Q26776151-60FA41B9-6C5E-4834-A378-0CD43259798C Q26823090-A55010E7-17C5-46A1-AEDD-C426524A7349 Q27024229-ECD9CDAE-C0D8-4C5C-9535-83843857864B Q30581482-9F91608F-4A52-494C-8C5C-066A272335C1 Q30991629-49419E77-914D-4E57-8546-BAFC469C1F22 Q33410603-0D89184C-61DD-4BF2-98DA-FADB4A1F1626 Q35532450-9EF04B60-1002-43F6-88C9-12E5D050F467 Q37561282-2BA998F0-70B3-4A44-A3D8-4799D23D6667 Q38029245-150BA219-4E6F-4BD2-995E-75EB05816EA0 Q38223160-D96C75D8-EB81-42D4-ACA1-C7A8CB9C92EC Q38619244-63328B46-452B-4489-9BE2-5EEEE7E4F172 Q38691467-95E3DA2A-7CED-40EE-89DB-A1D35BCB6F8F Q38794406-2ED75741-4D7F-458F-B6AE-A6E37B12EE6B Q38833567-A8524A9E-066E-4BA0-B339-007987375F3F Q39194877-0231B3EF-9E44-483B-96A2-B9FF0685A906 Q39258590-5393C360-E02A-46C4-AEC9-2A2DE9FDC404 Q39803518-C4115958-99B7-434D-AF75-AF214DE83231 Q40250056-786251C3-981D-4AD4-9C80-5BD71DCBAEA5 Q40492215-E5E68387-06AC-4F61-A57D-6060F3803E30 Q40703339-058FF9FA-7144-4AE1-B6E7-6A9014F3A071 Q40879703-06657B00-24D5-4228-BCF7-2A466BB215B4 Q41704739-18A8FA94-8835-4368-A732-75F77EB9FD64 Q42242814-F2876243-C0B4-49F0-92F2-EEF5772F07EB Q42251789-470A4D9D-9ED8-4F9F-83B3-A311D2C73CB7 Q42263131-3A5E0BC4-F300-4F3B-BC00-BAF196F7BB5D Q42272334-D46BB320-BADF-4FE4-BE57-8DCAC30012CD Q45083617-BB57FCBA-6CCD-4BFF-AC87-47A0E0F838BC Q47148062-CE37C200-1079-43F2-B1DA-42B6B0B56838 Q47552449-4B33CF64-5BBC-4461-8F74-9CBB9F7A0805 Q47572480-337762CD-6359-4F6C-9410-92570474C080 Q47604346-6B143EAC-90CA-4D45-8B29-48E36D4AC3DB Q47799831-1C3F0EEE-2603-4385-8015-E09751CEFB02 Q49152860-F0BFBDCA-F2C9-4BB5-8D37-58E76061EFAB Q51734713-B2466554-99E0-4C1F-AB6C-A3EE64604F98 Q55266341-94D9AA03-5576-430C-A6FF-E51F49E12EB2 Q57153233-25E287FC-28EF-42B0-9C6B-3A93A0E23645

P2860

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

http://www.wikidata.org/entity/Q56908048

description

article

@en

im Januar 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2012

@uk

name

Epidemiology of Posttransplant ...... ysis of Subgroups of Lymphomas

@en

Epidemiology of Posttransplant ...... ysis of Subgroups of Lymphomas

@nl

type

label

Epidemiology of Posttransplant ...... ysis of Subgroups of Lymphomas

@en

Epidemiology of Posttransplant ...... ysis of Subgroups of Lymphomas

@nl

prefLabel

Epidemiology of Posttransplant ...... ysis of Subgroups of Lymphomas

@en

Epidemiology of Posttransplant ...... ysis of Subgroups of Lymphomas

@nl

P1433

Q56908048-A9904DF5-E9DB-4398-90F1-0C71537F6D96

P1476

Q56908048-89462112-CE5C-4155-A6D5-DFBFD6CAF5D3

P2093

Q56908048-3234DDFD-8AD0-4599-986C-B6E31C37E785

Q56908048-49B00787-4250-4177-AAC3-F54861BE3830

Q56908048-5D1E6342-6665-434B-BF4E-8188AA64A998

Q56908048-8629F5B6-F1FA-45BD-A48A-1B514BCB4489

Q56908048-91C7FF98-3CB2-4B4A-893E-5A4E73C7548E

Q56908048-B6797981-7186-46A9-A7DB-0485FA5C9A81

Q56908048-C11FCE01-A1F3-4E4D-BDAA-BBA2314108AF

P2860

Q56908048-0B36D413-F027-4AC3-9070-40510A549AE8

Q56908048-11565BC1-4323-4DC3-A12D-D78B383484C1

Q56908048-22695A6D-080B-4ECD-B96E-DB65767BCE17

Q56908048-254F4F64-F584-4D53-B993-807A9B908F78

Q56908048-28707D7D-AD1B-4D39-BB8B-16385607820F

Q56908048-451A4AAE-6DC8-4EB7-898C-E0CF7D78DF83

Q56908048-45E01EDE-1345-4A17-A8DB-176719876F58

Q56908048-46E135C1-6E3E-484D-BF9A-EF54CA9BBB6E

Q56908048-503F7473-9061-461F-8A2C-A8525208AF89

Q56908048-505FDDAB-CC58-4432-A6AF-D20EB5627BA2

P304

Q56908048-0C779E7E-0220-4C60-8BE4-C608A59D66D9

P31

Q56908048-9CE24C00-C222-4F1F-9615-8AB46DE00EDD

P356

Q56908048-8F61C1D0-DA9E-4A4F-B4E9-BA35407347C8

P407

Q56908048-D1571F79-4CB6-47C0-AF03-8B9831859360

P433

Q56908048-D7397842-8357-4894-BD2B-B3FB087D3C7F

P478

Q56908048-3EAEDA44-E336-4482-906B-84247524DC41

P50

Q56908048-B8B77FFF-08FB-4E62-A273-C7D01AAE04CF

Q56908048-C540744D-1C54-4196-9135-44DE16AE892C

P577

Q56908048-EA4DE3CE-6DE6-4A1D-A456-F7691345C7BB

P698

Q56908048-A57A9CF7-CEC1-4BB0-875F-DFBD6B55AD15

P921

Q56908048-CEA3414A-E432-46CE-B682-F5BC882E0CD5

P356

J.1600-6143.2011.03896.X

P1433

American Journal of Transplantation

P1476

Epidemiology of posttransplant ...... ysis of subgroups of lymphomas

@en

P2093

C Quelen

http://www.w3.org/2001/XMLSchema#string

French Transplant Centers

http://www.w3.org/2001/XMLSchema#string

J Dantal

http://www.w3.org/2001/XMLSchema#string

M Velten

http://www.w3.org/2001/XMLSchema#string

P Lang

http://www.w3.org/2001/XMLSchema#string

S Caillard

http://www.w3.org/2001/XMLSchema#string

Y Lebranchu

http://www.w3.org/2001/XMLSchema#string

P2860

Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

Epstein-Barr virus and post-transplant lymphoproliferative disease.

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States

Lymphoproliferative disease after renal transplantation in Australia and New Zealand.

Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.

The non-Hodgkin lymphomas: a review of the epidemiologic literature.

P304

682-693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-6143.2011.03896.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22226336

http://www.w3.org/2001/XMLSchema#string

P921